TheraPure™ Modifying Enzymes
TheraPure™ Modifying Enzymes
Thermo Scientific™

TheraPure™ Modifying Enzymes

Thermo Scientific TheraPure in vitro transcription (IVT) enzymes are designed for advanced research and early development of mRNA therapeutics and vaccines.
Have Questions?
Cambiar vistabuttonViewtableView
Número de catálogoCantidadConcentraciónTipo de producto
EF022T110 U, 100 μL0,1 U/μlPirofosfatasa, inorgánica
EN052T15000 U, 100 μL50 U/μlADNasa I, sin ARNasa
EO038T110 000 U, 250 μL40 U/μlInhibidor de la RNasa
EF0221T110 U, 10 μL1 U/μlPirofosfatasa, inorgánica
Número de catálogo EF022T1
Precio (MXN)
-
Cantidad:
10 U, 100 μL
Concentración:
0,1 U/μl
Tipo de producto:
Pirofosfatasa, inorgánica
Thermo Scientific TheraPure in vitro transcription (IVT) enzymes are designed for advanced research and early development of mRNA therapeutics and vaccines. These products offer full workflow solutions from template preparation to RNA synthesis and are recommended for process research and optimization, proof of concept, and preclinical studies.

The high purity of TheraPure IVT enzymes is ensured by precise quality testing that includes confirmation that that the enzymes are nuclease- and endotoxin-free. In addition, the manufacturing process of TheraPure products follows ISO9001 and ISO13485 standards.

Features

  • Convenient stand-alone enzymes for easy workflow optimization
  • Animal-origin-free (AOF) raw materials used in manufacturing
  • No risk of prion or animal virus contamination
  • Reproducible and consistent results with validated quality testing
  • Regulatory compliant—β-lactam-free manufacturing technology
  • Suitable for translational research
  • Facilitates transition to GMP during mRNA vaccine development process
  • Scalable and available as OEM product

The exceptional quality of TheraPure products is supported by:

  • Certificates of analysis
  • Certificates of origin
  • TSE/BSE statement
Para uso exclusivo en investigación.
Especificaciones
Para utilizar con (aplicación)In vitro Transcription
InhibidoresImidodiphosphate, α ω-glycol disphosphates, methanedial diphosphate, 1,2-ethanedial diphosphate
Peso molecular32 kDa
Tipo de productoPirofosfatasa, inorgánica
Cantidad10 U, 100 μL
Aplicación validadaRNA synthesis
Concentración0,1 U/μl
EnzimaPyrophosphatase, inorganic
FormularioLíquido
Línea de productosTheraPure
Categoría de investigaciónDrug Development
Sensible a la inactivación del calorNo
Unit SizeEach